These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 8579962)

  • 21. Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats.
    Iwaniec UT; Magee KA; Mitova-Caneva NG; Wronski TJ
    Bone; 2003 Sep; 33(3):380-6. PubMed ID: 13678780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
    Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
    Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats.
    Shen Y; Li M; Wronski TJ
    Calcif Tissue Int; 1997 May; 60(5):457-61. PubMed ID: 9115164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
    Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
    Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
    Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
    J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats.
    Goss PE; Qi S; Cheung AM; Hu H; Mendes M; Pritzker KP
    J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):79-87. PubMed ID: 15544933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alfacalcidol restores cancellous bone in ovariectomized rats.
    Li M; Healy DR; Simmons HA; Ke HZ; Thompson DD
    J Musculoskelet Neuronal Interact; 2003 Mar; 3(1):39-46. PubMed ID: 15758364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
    Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
    Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of progestins on the metabolism of cancellous bone in aged oophorectomized rats.
    Yamamoto Y; Kurabayashi T; Tojo Y; Yahata T; Honda A; Tomita M; Tanaka K
    Bone; 1998 May; 22(5):533-7. PubMed ID: 9600788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats.
    Saino H; Matsuyama T; Takada J; Kaku T; Ishii S
    J Bone Miner Res; 1997 Nov; 12(11):1844-50. PubMed ID: 9383689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats.
    Ma YL; Bryant HU; Zeng Q; Palkowitz A; Jee WS; Turner CH; Sato M
    J Bone Miner Res; 2002 Dec; 17(12):2256-64. PubMed ID: 12469920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
    Sato M; Zeng GQ; Rowley E; Turner CH
    Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
    Kidder LS; Schmidt IU; Evans GL; Turner RT
    Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models.
    Ke HZ; Paralkar VM; Grasser WA; Crawford DT; Qi H; Simmons HA; Pirie CM; Chidsey-Frink KL; Owen TA; Smock SL; Chen HK; Jee WS; Cameron KO; Rosati RL; Brown TA; Dasilva-Jardine P; Thompson DD
    Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat.
    Erben RG; Kohn B; Weiser H; Sinowatz F; Rambeck WA
    Z Ernahrungswiss; 1990 Dec; 29(4):229-48. PubMed ID: 2080635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
    Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
    J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.